Your browser doesn't support javascript.
loading
Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement.
Gray, Belinda; Semsarian, Christopher; Fatkin, Diane; Ingles, Jodie; Atherton, John J; Davis, Andrew M; Sanders, Prashanthan; Pachter, Nicholas; Skinner, Jonathan R; Stiles, Martin K.
Afiliação
  • Gray B; Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, University of Sydney, and Royal Prince Alfred Hospital, Sydney, NSW, Australia. Electronic address: belinda.gray@sydney.edu.au.
  • Semsarian C; Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, University of Sydney, and Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Fatkin D; Victor Chang Cardiac Research Institute, Sydney, NSW, Australia; St Vincent's Hospital, Sydney, and University of New South Wales, Sydney, NSW, Australia.
  • Ingles J; Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, University of Sydney, and Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Atherton JJ; Royal Brisbane and Women's Hospital, University of Queensland, University of Sunshine Coast, and University of Technology, Brisbane, Qld, Australia.
  • Davis AM; The Royal Children's Hospital, Murdoch Children's Institute and The University of Melbourne, Melbourne, Vic, Australia.
  • Sanders P; Centre for Heart Rhythm Disorders (CHRD), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide and Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Pachter N; Genetic Services of Western Australia, Perth, WA, Australia.
  • Skinner JR; Starship Children's Hospital and The University of Auckland, Auckland, New Zealand.
  • Stiles MK; Waikato Hospital, Hamilton, New Zealand.
Heart Lung Circ ; 29(7): e85-e87, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32418874
ABSTRACT
In the context of the current global COVID-19 pandemic, this Consensus Statement provides current recommendations for patients with, or at risk of developing, genetic heart disease, and for their health care management and service provision in Australia and New Zealand. Apart from general recommendations, there are specific recommendations for the following conditions cardiomyopathy, Brugada syndrome (including in children), long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT). Other recommendations are relevant to patient self-care and primary health care.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Administração dos Cuidados ao Paciente / Cardiologia / Controle de Doenças Transmissíveis / Infecções por Coronavirus / Pandemias / Doença do Sistema de Condução Cardíaco Limite: Adult / Child / Humans País/Região como assunto: Oceania Idioma: En Revista: Heart Lung Circ Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Administração dos Cuidados ao Paciente / Cardiologia / Controle de Doenças Transmissíveis / Infecções por Coronavirus / Pandemias / Doença do Sistema de Condução Cardíaco Limite: Adult / Child / Humans País/Região como assunto: Oceania Idioma: En Revista: Heart Lung Circ Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2020 Tipo de documento: Article